Kimiyoshi Sakaguchi

14PUBLICATIONS
70CO-AUTHORS
Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples youth and familyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 25, 2026
Feasibility and Efficacy of Lorlatinib in Japanese Patients With Relapsed/Refractory ALK-Aberrant Neuroblastoma.

|May 22, 2026
Functional characterization of Griscelli syndrome type 2 sine albinism in Japanese patients.

|Jan 06, 2026
Combination of oral temozolomide and etoposide as palliative chemotherapy for recurrent or progressive neuroblastoma.

Katsutsugu Umeda, Satoshi Saida, Hirokazu Kobushi

|Dec 15, 2023
RNA sequencing and target long-read sequencing reveal an intronic transposon insertion causing aberrant splicing.

Ryota Kawakami, Takuya Hiraide, Kazuki Watanabe

|Nov 08, 2023
The parental involvement process regarding childhood cancer survivors becoming independent: Focus on balancing health management and social lives from adolescence to adulthood.

Kyoko Miyagishima, Kazuko Ichie, Kimiyoshi Sakaguchi

|Oct 15, 2023
Utility of ASNS gene methylation evaluated with the HPLC method as a pharmacogenomic biomarker to predict asparaginase sensitivity in BCP-ALL.

Atsushi Watanabe, Kunio Miyake, Yuriko Yamada

Pageof 3

Frequent Collaborators

3 joint publications

Hisashi Ishida

3 joint publications

Motohiro Kato

3 joint publications

Takako Miyamura

2 joint publications

Katsutsugu Umeda